H.B. No. 163 amends the Health and Safety Code regarding the possession and administration of epinephrine delivery systems by certain entities. The bill introduces a new subsection (a-1) which clarifies that the section does not apply to entities that are mandated by other laws to have a policy for the maintenance, administration, and disposal of epinephrine delivery systems. Additionally, it modifies subsection (c) to specify that entities, including governmental ones, may adopt policies concerning these systems, while removing references to "auto-injectors."

Furthermore, the bill repeals sections 773.0145(a) and (b) of the Health and Safety Code, streamlining the regulations surrounding epinephrine delivery systems. The changes aim to ensure that entities are compliant with existing laws while allowing flexibility in policy adoption. The act is set to take effect on September 1, 2025.

Statutes affected:
Introduced: Health and Safety Code 773.0145 (Health and Safety Code 773)
House Committee Report: Health and Safety Code 773.0145 (Health and Safety Code 773)
Engrossed: Health and Safety Code 773.0145 (Health and Safety Code 773)
Senate Committee Report: Health and Safety Code 773.0145 (Health and Safety Code 773)
Enrolled: Health and Safety Code 773.0145 (Health and Safety Code 773)